• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清三甲胺 N-氧化物与 2 型糖尿病并发糖尿病肾病患者肠道微生物多样性的关系。

Serum Trimethylamine N-oxide and the Diversity of the Intestinal Microbial Flora in Type 2 Diabetes Complicated by Diabetic Kidney Disease.

出版信息

Clin Lab. 2022 May 1;68(5). doi: 10.7754/Clin.Lab.2021.210836.

DOI:10.7754/Clin.Lab.2021.210836
PMID:35536069
Abstract

BACKGROUND

Trimethylamine N-oxide (TMAO) serves as a metabolite of intestinal bacteria as well as a urotoxin influencing the prognosis of chronic kidney disease (CKD), which has become a research hotspot in the field of kidney disease. This study preliminarily explored the alternations of the microbial flora and serum TMAO in patients with type 2 diabetes mellitus (T2DM) complicated with diabetic kidney disease (DKD).

METHODS

Seventeen T2DM patients at the Affiliated Hospital of Zunyi Medical University between September 2018 and February 2019 were included. Among these patients, 8 patients had T2DM complicated with DKD. Eight healthy volunteers constituted the control group. Fresh stool was collected for Illumina sequencing. Based on the sequencing outcomes, the flora diversity and species differences were analyzed. Serum TMAO, cystatin C, urinary albumin/urine creatinine ratios (ACRs), and routine biochemical outcomes were also compared.

RESULTS

The DKD group exhibited a significantly higher TMAO level than the remaining groups. The high-TMAO group had a significantly increased ACR level compared with the low-TMAO group. TMAO positively correlated with the ACR. Compared with the control group, the DKD group exhibited a decreased flora diversity. At the genus level, both the T2DM group and the DKD group showed decreased numbers of Alloprevotella and Megasphaera compared with the control group. The difference in Megasphaera between the DKD group and the control group was significant.

CONCLUSIONS

The alternation of the intestinal microbial flora may participate in the development of DKD, and TMAO and chronic inflammation might be important factors for DKD development.

摘要

背景

三甲胺 N-氧化物(TMAO)作为肠道细菌的代谢产物和影响慢性肾脏病(CKD)预后的尿毒素,已成为肾脏病领域的研究热点。本研究初步探讨了 2 型糖尿病(T2DM)合并糖尿病肾病(DKD)患者肠道菌群和血清 TMAO 的变化。

方法

纳入 2018 年 9 月至 2019 年 2 月遵义医科大学附属医院的 17 例 T2DM 患者,其中 8 例 T2DM 合并 DKD。8 例健康志愿者为对照组。采集新鲜粪便进行 Illumina 测序。根据测序结果,分析菌群多样性和物种差异。比较血清 TMAO、胱抑素 C、尿白蛋白/尿肌酐比值(ACR)和常规生化指标。

结果

与其余组相比,DKD 组 TMAO 水平明显升高。高 TMAO 组 ACR 水平明显高于低 TMAO 组。TMAO 与 ACR 呈正相关。与对照组相比,DKD 组菌群多样性降低。在属水平上,T2DM 组和 DKD 组的 Alloprevotella 和 Megasphaera 数量均低于对照组。DKD 组与对照组之间 Megasphaera 的差异具有统计学意义。

结论

肠道微生物菌群的改变可能参与 DKD 的发生,TMAO 和慢性炎症可能是 DKD 发生的重要因素。

相似文献

1
Serum Trimethylamine N-oxide and the Diversity of the Intestinal Microbial Flora in Type 2 Diabetes Complicated by Diabetic Kidney Disease.血清三甲胺 N-氧化物与 2 型糖尿病并发糖尿病肾病患者肠道微生物多样性的关系。
Clin Lab. 2022 May 1;68(5). doi: 10.7754/Clin.Lab.2021.210836.
2
Elevated serum trimethylamine oxide levels as potential biomarker for diabetic kidney disease.血清氧化三甲胺水平升高作为糖尿病肾病的潜在生物标志物。
Endocr Connect. 2023 Jul 5;12(8):e220542. doi: 10.1530/EC-22-0542.
3
Vitamin D is involved in the effects of the intestinal flora and its related metabolite TMAO on perirenal fat and kidneys in mice with DKD.维生素 D 参与了肠道菌群及其相关代谢物 TMAO 对 DKD 小鼠肾周脂肪和肾脏的影响。
Nutr Diabetes. 2024 Jun 10;14(1):42. doi: 10.1038/s41387-024-00297-z.
4
Enhanced trimethylamine metabolism and gut dysbiosis in type 2 diabetes mellitus with microalbumin.2 型糖尿病伴微量白蛋白尿患者中三甲基胺代谢增强和肠道菌群失调。
Front Endocrinol (Lausanne). 2023 Nov 20;14:1257457. doi: 10.3389/fendo.2023.1257457. eCollection 2023.
5
Effects of tetragonum tablets and Jin Gui Ren Qi Pill on intestinal flora and metabolism in patients with diabetic kidney disease.四方片和金匮肾气丸对糖尿病肾病患者肠道菌群及代谢的影响。
Front Pharmacol. 2024 Jul 29;15:1346168. doi: 10.3389/fphar.2024.1346168. eCollection 2024.
6
Zuogui-Jiangtang-Yishen decoction prevents diabetic kidney disease: Intervene pyroptosis induced by trimethylamine n-oxide through the mROS-NLRP3 axis.左归降糖益肾汤防治糖尿病肾病:通过 mROS-NLRP3 轴干预氧化三甲胺诱导的细胞焦亡。
Phytomedicine. 2023 Jun;114:154775. doi: 10.1016/j.phymed.2023.154775. Epub 2023 Mar 18.
7
Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.尿细胞外囊泡中的尿调蛋白 mRNA 与 2 型糖尿病患者的肾功能下降相关。
Am J Nephrol. 2018;47(5):283-291. doi: 10.1159/000489129. Epub 2018 May 18.
8
Serum and Urinary Progranulin in Diabetic Kidney Disease.糖尿病肾病中的血清和尿颗粒蛋白前体
PLoS One. 2016 Oct 24;11(10):e0165177. doi: 10.1371/journal.pone.0165177. eCollection 2016.
9
Trimethylamine N-Oxide Exacerbates Renal Inflammation and Fibrosis in Rats With Diabetic Kidney Disease.氧化三甲胺加剧糖尿病肾病大鼠的肾脏炎症和纤维化。
Front Physiol. 2021 Jun 16;12:682482. doi: 10.3389/fphys.2021.682482. eCollection 2021.
10
Diabetic Nephropathy Can Be Treated with Calcium Dobesilate by Alleviating the Chronic Inflammatory State and Improving Endothelial Cell Function.羟苯磺酸钙可通过减轻慢性炎症状态和改善内皮细胞功能来治疗糖尿病肾病。
Cell Physiol Biochem. 2018;51(3):1119-1133. doi: 10.1159/000495491. Epub 2018 Nov 26.

引用本文的文献

1
Fecal microbiota transplantation is a promising therapy for kidney diseases.粪便微生物群移植是一种很有前景的肾脏疾病治疗方法。
Front Med (Lausanne). 2025 Jul 9;12:1628722. doi: 10.3389/fmed.2025.1628722. eCollection 2025.
2
The gut microbiota and diabetic nephropathy: an observational study review and bidirectional Mendelian randomization study.肠道微生物群与糖尿病肾病:一项观察性研究综述及双向孟德尔随机化研究
Trials. 2025 Mar 24;26(1):101. doi: 10.1186/s13063-025-08755-4.
3
Kidney tea [ (Blume) Miq.] improves diabetic nephropathy via regulating gut microbiota and ferroptosis.
肾茶[(Blume)Miq.]通过调节肠道微生物群和铁死亡改善糖尿病肾病。
Front Pharmacol. 2024 Jun 19;15:1392123. doi: 10.3389/fphar.2024.1392123. eCollection 2024.
4
Traditional Chinese medicine improved diabetic kidney disease through targeting gut microbiota.中医通过靶向肠道微生物群改善糖尿病肾病。
Pharm Biol. 2024 Dec;62(1):423-435. doi: 10.1080/13880209.2024.2351946. Epub 2024 May 17.
5
Causal relationship between gut microbiota and diabetic nephropathy: a two-sample Mendelian randomization study.肠道微生物群与糖尿病肾病的因果关系:两样本孟德尔随机化研究。
Front Immunol. 2024 Mar 8;15:1332757. doi: 10.3389/fimmu.2024.1332757. eCollection 2024.
6
Trimethylamine N-oxide and kidney diseases: what do we know?三甲基胺 N-氧化物与肾脏疾病:我们了解多少?
J Bras Nefrol. 2024 Jan-Mar;46(1):85-92. doi: 10.1590/2175-8239-JBN-2023-0065en.
7
The potential mechanism of gut microbiota-microbial metabolites-mitochondrial axis in progression of diabetic kidney disease.肠道微生物群-微生物代谢物-线粒体轴在糖尿病肾病进展中的潜在机制。
Mol Med. 2023 Oct 31;29(1):148. doi: 10.1186/s10020-023-00745-z.
8
The pathogenic role of intestinal flora metabolites in diabetic nephropathy.肠道菌群代谢产物在糖尿病肾病中的致病作用。
Front Physiol. 2023 Jul 4;14:1231621. doi: 10.3389/fphys.2023.1231621. eCollection 2023.
9
A systematic review and meta-analysis of gut microbiota in diabetic kidney disease: Comparisons with diabetes mellitus, non-diabetic kidney disease, and healthy individuals.糖尿病肾病患者肠道微生物组的系统评价和荟萃分析:与糖尿病、非糖尿病肾病和健康个体的比较。
Front Endocrinol (Lausanne). 2022 Oct 20;13:1018093. doi: 10.3389/fendo.2022.1018093. eCollection 2022.
10
Serum Trimethylamine N-Oxide Level Is Associated with Peripheral Arterial Stiffness in Advanced Non-Dialysis Chronic Kidney Disease Patients.血清三甲胺 N-氧化物水平与晚期非透析慢性肾脏病患者的外周动脉僵硬度相关。
Toxins (Basel). 2022 Jul 31;14(8):526. doi: 10.3390/toxins14080526.